Quelques publications récentes
Xie, S.C., # Metcalfe, R.D., # Dunn, E., Morton, C.J., Huang, S-C., Puhalovich, T., Du, Y., Wittlin, S., Nie, S., Luth, M.R., Ma, L., Kim, M-S., Pasaje, C.F.A., Kumpornsin, K., Giannangelo, C., Houghton, F.J., Churchyard, A., Famodimu, M.T., Barry, D.C., Gillett, D.L., Dey, S., Kosasih, C.C., Newman, W., Niles, J.C., Lee, M.C.S., Baum, J., Ottilie, S., Winzeler, E.A., Creek, D.J., Williamson, N., Parker, M.W., Brand, S., Langston, S.,* Dick, L.R.,* Griffin, M.D.W.,* Gould, A.E.* and Tilley, L.* (2022) Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy. Science 376, 1074–1079. Access to manuscript and commentaries TiP, CHM & Science
Li, J.#, Shami, G.J.#, Cho, E., Liu, B., Hanssen, E., Dixon, M.W.A*., Tilley, L*. Repurposing the mitotic machinery to drive cellular elongation and chromatin reorganisation in Plasmodium falciparum gametocytes. Nature Communications (accepted Aug 5, 2022).
Carmo, O.M.S.,. Shami, G.J., Cox, D., Liu, B., Blanch, A.J., Tiash, S., Tilley, L.*, Dixon M.W.A.* (2022) Virulence determinant, PTP7, controls vesicle budding from the Maurer’s clefts, adhesin protein trafficking and host cell remodeling in Plasmodium falciparum. PLoS Pathogens (Published: August 5, 2022)
Xie, S.C. Metcalfe, R.D., Mizutani, H., Puhalovich, T., Hanssen, E., Morton, C.J., Du, Y. Huang, S-C., Ciavarri, J., Hales, P., Griffin, R.J., Cohen, L.H., Chuang, B-C., Wittlin, S., Deni, I., Yeo, I., Barry, D.C., Liu, B., Gillett, D.L., Crespo-Fernandez, B.F., Ottilie, S., Mittal, N., Churchyard, A., Ferguson, D., Aguiar, A.C.C., Guido, R.V.C., Baum, J., Hanson, K.K., Winzeler, E.A., Gamo, F.J., Fidock, D.A., Baud, D., Parker, M.W., Brand, S., Dick, L.R., Griffin, M.D.W.,* Gould, A.E.* and Tilley, L.* (2021) Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences, USA 118 (39) e2107213118.
Invitée par Catherine Lavazec
Pour obtenir le lien de visioconférence , contacter par mail